Avandia Linked to Congestive Heart Failure and Death
In 2007 researchers believed the diabetes drug Avandia might triple heart risks. And now they know for sure! A new study in the Archives of Internal Medicine reveals elderly diabetics taking rosiglitazone, the other name for Avandia, were more likely to suffer congestive heart failure and more likely to die; The New York Times reports.
